Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials
Osteoporosis International · 2024
DOI: 10.1007/s00198-024-07049-w ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Osteoporosis International, 2024. Verfasst von J Lane und 8 weiteren Autor:innen. Beteiligte Einrichtung: HSS Ambulatory Care Center, New York, NY, USA. Hauptthemen laut MEDLINE: Osteoporotic Fractures, Bone Density Conservation Agents, Spinal Fractures, Osteoporosis, Postmenopausal. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UCB Pharma and Amgen Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HSS Ambulatory Care Center, New York, NY, USA.
- Aarhus University Hospital, Aarhus, Denmark.
- University Hospital Llandough, Cardiff and Vale University Health Board, Cardiff, Wales.
- Department of Orthopaedic and Trauma Surgery Center for Orthopaedic and Trauma Surgery, Marienhaus Klinikum Mainz, Major Teaching Hospital, University Medicine Mainz, Mainz, Germany.
- Amgen Inc, Thousand Oaks, CA, USA.
- UCB Pharma, Slough, UK.
Förderung
- UCB Pharma and Amgen Inc
Zitieren
APA
Lane, J., Langdahl, B., Stone, M., Kurth, A., Oates, M., Timoshanko, J., Wang, Z., Libanati, C., & Cosman, F. (2024). Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis International. https://doi.org/10.1007/s00198-024-07049-w
Vancouver
Lane J, Langdahl B, Stone M, Kurth A, Oates M, Timoshanko J, et al. Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials. Osteoporosis International. 2024. doi:10.1007/s00198-024-07049-w
BibTeX
@article{Lane2024,
author = {Lane, J and Langdahl, B and Stone, M and Kurth, A and Oates, M and Timoshanko, J and Wang, Z and Libanati, C and Cosman, F},
title = {Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials},
journal = {Osteoporosis International},
year = {2024},
doi = {10.1007/s00198-024-07049-w}
}
EUVIMED